CLYM CIK: 1768446

Climb Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.1
FY22:
−37.4
FY23:
−20.6
FY24:
−15.6
FY25:
−54.4
Change from FY21 to FY25
millions USD
FY21:
−115
FY22:
34.4
FY23:
69.0
FY24:
−121
FY25:
2.83
Change from FY21 to FY25
millions USD
FY21:
177
FY22:
0
FY23:
0.84
FY24:
131
FY25:
−0.02
millions USD
FY21:
26.4
FY22:
−3.34
FY23:
49.5
FY24:
−5.88
FY25:
−51.5
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−20.6
FY24:
−15.6
FY25:
−54.5

All amounts in millions USD Data source:SEC EDGAR